Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1998 1
1999 1
2003 1
2004 2
2006 2
2007 1
2008 2
2009 1
2010 2
2011 6
2012 5
2013 2
2014 4
2015 2
2016 4
2017 2
2018 4
2019 4
2020 5
2021 2
2022 5
2023 1
2024 4
2025 4
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
In vitro and in vivo validation studies of optimized iron oxide nanoparticles carrying targeting ligands for a new therapeutic strategy in head and neck cancers.
Furgiuele S, Gevart T, Freis B, Ramirez MLA, Descamps G, Boutry S, Larbanoix L, Sant'Angelo D, Trelcat A, Saussez S, Bégin-Colin S, Journe F, Laurent S. Furgiuele S, et al. Among authors: descamps g. Nanoscale Adv. 2025 Sep 3;7(21):6987-7002. doi: 10.1039/d5na00361j. eCollection 2025 Oct 21. Nanoscale Adv. 2025. PMID: 40994521 Free PMC article.
VDAC2 primes myeloma cells for BAK-dependent apoptosis and represents a novel therapeutic target.
Champion O, Maïga S, Antier C, Dousset C, Moreau-Aubry A, Bellanger C, Guillonneau F, Descamps G, Moreno JA, Kwon O, Lilli NL, Moreau P, Chiron D, Pellat-Deceunynck C, Touzeau C, Gomez-Bougie P. Champion O, et al. Among authors: descamps g. Leukemia. 2025 Apr;39(4):995-1000. doi: 10.1038/s41375-025-02523-8. Epub 2025 Feb 6. Leukemia. 2025. PMID: 39915649 Free PMC article. No abstract available.
Combined inhibition of CTPS1 and ATR is a metabolic vulnerability in p53-deficient myeloma cells.
Durand R, Bellanger C, Descamps G, Dousset C, Maïga S, Derrien J, Thirouard L, Bouard L, Asnagli H, Beer P, Parker A, Gomez-Bougie P, Devilder MC, Moreau P, Touzeau C, Moreau-Aubry A, Chiron D, Pellat-Deceunynck C. Durand R, et al. Among authors: descamps g. Hemasphere. 2024 Oct 8;8(10):e70016. doi: 10.1002/hem3.70016. eCollection 2024 Oct. Hemasphere. 2024. PMID: 39380841 Free PMC article.
A p53 score derived from TP53 CRISPR/Cas9 HMCLs predicts survival and reveals a major role of BAX in the response to BH3 mimetics.
Durand R, Descamps G, Bellanger C, Dousset C, Maïga S, Alberge JB, Derrien J, Cruard J, Minvielle S, Lilli NL, Godon C, Le Bris Y, Tessoulin B, Amiot M, Gomez-Bougie P, Touzeau C, Moreau P, Chiron D, Moreau-Aubry A, Pellat-Deceunynck C. Durand R, et al. Among authors: descamps g. Blood. 2024 Mar 28;143(13):1242-1258. doi: 10.1182/blood.2023021581. Blood. 2024. PMID: 38096363 Free article.
63 results